Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality

Controlling for selective dropout in longitudinal dementia data: Application to the SveDem registry

(2020) Ron Handels et al.   Alzheimers & Dementia

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease

(2019) Dan-Dan Li et al.   Frontiers in Neuroscience

Do Acetylcholinesterase Inhibitors Prevent or Delay Psychotropic Prescribing in People With Dementia? Analyses of the Swedish Dementia Registry

(2019) Edwin C.K. Tan et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Study of the strength of the evidence and the redundancy of the research on pharmacological treatment for Alzheimer’s disease: a cumulative meta-analysis and trial sequential analysis

(2019) Lídia Blanco-Silvente et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Acetylcholinesterase inhibitors and risk of stroke and death in people with dementia

(2018) Edwin C.K. Tan et al.   Alzheimers & Dementia

Short-Term Response to Cholinesterase Inhibitors in Alzheimer’s Disease Delays Time to Nursing Home Placement

(2018) Carina Wattmo et al.   Current Alzheimer Research

Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes

(2018) Miriam L. Haaksma et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry

(2018) Ana Subic et al.   JOURNAL OF ALZHEIMERS DISEASE

Prestroke Mobility and Dementia as Predictors of Stroke Outcomes in Patients Over 65 Years of Age: A Cohort Study From The Swedish Dementia and Stroke Registries

(2018) Sara Garcia-Ptacek et al.   Journal of the American Medical Directors Association

Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion

(2018) Marion T. Turnbull et al.   Frontiers in Molecular Neuroscience

Mortality Risk after Dementia Diagnosis by Dementia Type and Underlying Factors: A Cohort of 15,209 Patients based on the Swedish Dementia Registry

(2018) Sara Garcia-Ptacek et al.   JOURNAL OF ALZHEIMERS DISEASE

Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia

(2018) Edwin C.K. Tan et al.   JOURNAL OF ALZHEIMERS DISEASE

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors

(2018) Stefan J. Teipel et al.   Frontiers in Neurology

Stroke as a Cause of Death in Death Certificates of Patients with Dementia: A Cohort Study from the Swedish Dementia Registry

(2018) Ana Subic et al.   Current Alzheimer Research

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) Emma Nichols et al.   LANCET NEUROLOGY

Management of acute ischaemic stroke in patients with dementia

(2017) A. Subic et al.   JOURNAL OF INTERNAL MEDICINE

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)

(2016) Martin Knapp et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Donepezil and nursing home placement — benefits and costs

(2016) Vesna Jelic et al.   Nature Reviews Neurology

Association between acetylcholinesterase inhibitors and risk of stroke in patients with dementia

(2016) Yi-Ting Lin et al.   Scientific Reports

Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services

(2015) Carina Wattmo et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

(2015) R. Schmidt et al.   EUROPEAN JOURNAL OF NEUROLOGY

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

(2015) Robert Howard et al.   LANCET NEUROLOGY

SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice

(2015) Dorota Religa et al.   PLoS One

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease

(2014) Carina Wattmo et al.   BMC Neurology

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

(2013) George T. Grossberg et al.   CNS DRUGS

The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease

(2013) Peter Nordström et al.   EUROPEAN HEART JOURNAL

Progression of Alzheimer Disease in Europe: Data from the European ICTUS Study

(2012) B. Vellas et al.   Current Alzheimer Research

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

(2012) Robert Howard et al.   NEW ENGLAND JOURNAL OF MEDICINE

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine

(2011) Yukio Ago et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimers Disease: A Review of Recent Clinical Studies

(2010) T. Darreh-Shori et al.   Current Alzheimer Research

Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials

(2009) Bengt Winblad et al.   CURRENT MEDICAL RESEARCH AND OPINION

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research